Delineating Molecular Subtypes through Gene Set Variation Analysis Confers Therapeutic and Prognostic Capability in Gastric Cancer

Figure 5

Identification of prognostic gene sets by Lasso regression model. (a) Optimal values of λ were shown. (b) Coefficient profiles of core gene sets were calculated. (c) Survival analysis of gene sets in normal tissues. (d) Survival analysis of gene sets in tumor tissues. (e) Prognostic value of LASSO regression risk model based on gene sets in TCGA cohort. (f) Validation of prognostic of risk model in GEO cohort.

(a)

(b)

(c)

(d)

(e)

(f)